Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Tauber

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Advances in Therapy|June 19, 2002
Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitisJoseph Tauber,
Current Medical Research and Opinion|September 18, 2007
Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndromeJoseph Tauber
Cornea|January 3, 2020
A 6-Week, Prospective, Randomized, Single-Masked Study of Lifitegrast Ophthalmic Solution 5% Versus Thermal Pulsation Procedure for Treatment of Inflammatory Meibomian Gland DysfunctionJoseph Tauber
Ophthalmology|September 3, 2008
Ocular cicatricial pemphigoidJoseph Tauber
Cornea|April 2, 2026
Descemet Membrane Anterior Keratoplasty With BrightMEM Corneal Allograft: An Innovative Technique for Treatment of Nonhealing Diseases of the Ocular SurfaceJoshua H Hou, Joseph Tauber, Rajan Shukla
American Journal of Ophthalmology|February 2, 2021
Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye DiseaseDavid Clark, Joseph Tauber, John Sheppard, et al.
Ophthalmology and Therapy|December 11, 2023
Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective StudyKatherine Bickle, Jason R Miller, Joseph Tauber, et al.
Cornea|August 9, 2022
Lacripep for the Treatment of Primary Sjögren-Associated Ocular Surface Disease: Results of the First-In-Human StudyJoseph Tauber, Gordon W Laurie, Edward C Parsons, et al.
Ophthalmology|August 17, 2005
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 yearsLaurie D Barber, Stephen C Pflugfelder, Joseph Tauber, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 28, 2020
Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical TrialJoseph Tauber, James Owen, Marc Bloomenstein, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Advances in Therapy|June 19, 2002
Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitisJoseph Tauber,
Current Medical Research and Opinion|September 18, 2007
Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndromeJoseph Tauber
Cornea|January 3, 2020
A 6-Week, Prospective, Randomized, Single-Masked Study of Lifitegrast Ophthalmic Solution 5% Versus Thermal Pulsation Procedure for Treatment of Inflammatory Meibomian Gland DysfunctionJoseph Tauber
Ophthalmology|September 3, 2008
Ocular cicatricial pemphigoidJoseph Tauber
Cornea|April 2, 2026
Descemet Membrane Anterior Keratoplasty With BrightMEM Corneal Allograft: An Innovative Technique for Treatment of Nonhealing Diseases of the Ocular SurfaceJoshua H Hou, Joseph Tauber, Rajan Shukla
American Journal of Ophthalmology|February 2, 2021
Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye DiseaseDavid Clark, Joseph Tauber, John Sheppard, et al.
Ophthalmology and Therapy|December 11, 2023
Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective StudyKatherine Bickle, Jason R Miller, Joseph Tauber, et al.
Cornea|August 9, 2022
Lacripep for the Treatment of Primary Sjögren-Associated Ocular Surface Disease: Results of the First-In-Human StudyJoseph Tauber, Gordon W Laurie, Edward C Parsons, et al.
Ophthalmology|August 17, 2005
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 yearsLaurie D Barber, Stephen C Pflugfelder, Joseph Tauber, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 28, 2020
Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical TrialJoseph Tauber, James Owen, Marc Bloomenstein, et al.
Pageof 4